First Time Loading...
M

Mayinglong Pharmaceutical Group Co Ltd
SSE:600993

Watchlist Manager
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Watchlist
Price: 27.42 CNY 1.56% Market Closed
Updated: Apr 28, 2024

Mayinglong Pharmaceutical Group Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mayinglong Pharmaceutical Group Co Ltd
Operating Income Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
M
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Operating Income
¥456.9m
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
10%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Operating Income
¥7.7B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
23%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥3.7B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.3B
CAGR 3-Years
22%
CAGR 5-Years
22%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥3.6B
CAGR 3-Years
-17%
CAGR 5-Years
-3%
CAGR 10-Years
10%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥3.7B
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
6%

See Also

What is Mayinglong Pharmaceutical Group Co Ltd's Operating Income?
Operating Income
456.9m CNY

Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Operating Income amounts to 456.9m CNY.

What is Mayinglong Pharmaceutical Group Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
10%

Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for Mayinglong Pharmaceutical Group Co Ltd have been 7% over the past three years , 8% over the past five years , and 10% over the past ten years .